Cargando…

Functional in silico analysis of missense mutations in the MSH6 gene

Detalles Bibliográficos
Autores principales:	Gajdel, Katarzyna, Kurzawski, Grzegorz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4565071/ http://dx.doi.org/10.1186/1897-4287-13-S1-A10

Ejemplares similares

The pathological significance of selected MLH1 missense mutations based on the theoretical in silico predictions
por: Dubanowicz, Mariola
Publicado: (2015)

Identification of new genetic alterations in MLH1, MSH2 and MSH6 using IHC and HRM analysis in Lynch syndrome-suspected patients
por: Mazurek, A, et al.
Publicado: (2012)

Lynch syndrome mutations in Poland and the Baltic States
por: Dymerska, Dagmara, et al.
Publicado: (2015)

MSH6 missense mutations are often associated with no or low cancer susceptibility
por: Kariola, R, et al.
Publicado: (2004)

Loss of MSH6 and PMS2 immunohistochemical staining in tumour tissue of two individuals with a germline PMS2 mutation
por: Edwards, E, et al.
Publicado: (2012)

Substantial unexplained variation in cancer risks for MLH1 and MSH2 mutation carriers
por: Dowty, JG, et al.
Publicado: (2012)

MSH2 and MLH1 testing
por: Kurzawski, Grzegorz, et al.
Publicado: (2008)

In silico and in vivo splicing analysis of MLH1 and MSH2 missense mutations shows exon- and tissue-specific effects
por: Lastella, Patrizia, et al.
Publicado: (2006)

Fast diagnostic test for the identification of an increased genetic predisposition to colon cancer (exemplified on a DNA test for recurrent mutations of the gene MMR)
por: Kurzawski, G, et al.
Publicado: (2012)

Estimation of probabilities in favour of pathogenicity for missense substitutions for use in clinical evaluation of mismatch repair gene variants
por: Thompson, B, et al.
Publicado: (2012)

MSH2 missense mutations alter cisplatin cytotoxicity and promote cisplatin-induced genome instability
por: Clodfelter, Jill E., et al.
Publicado: (2005)

Selenium and cancer risk in CHEK2 mutation carriers
por: Gupta, Satish, et al.
Publicado: (2012)

MSH2–MSH6 stimulates DNA polymerase η, suggesting a role for A:T mutations in antibody genes
por: Wilson, Teresa M., et al.
Publicado: (2005)

Functional examination of MLH1, MSH2, and MSH6 intronic mutations identified in Danish colorectal cancer patients
por: Petersen, Sanne M, et al.
Publicado: (2013)

Somatic Hypermutation in Muts Homologue (Msh)3-, Msh6-, and Msh3/Msh6-Deficient Mice Reveals a Role for the Msh2–Msh6 Heterodimer in Modulating the Base Substitution Pattern
por: Wiesendanger, Margrit, et al.
Publicado: (2000)

Missense mutations of MLH1 and MSH2 genes detected in patients with gastrointestinal cancer are associated with exonic splicing enhancers and silencers
por: ZHU, MING, et al.
Publicado: (2013)

Complex MSH2 and MSH6 mutations in hypermutated microsatellite unstable advanced prostate cancer
por: Pritchard, Colin C., et al.
Publicado: (2014)

Combined iPLEX and TaqMan assays to screen for 45 common mutations in Lynch syndrome and FAP patients
por: Dymerska, D, et al.
Publicado: (2011)

Massively parallel functional testing of MSH2 missense variants conferring Lynch syndrome risk
por: Jia, Xiaoyan, et al.
Publicado: (2021)

In silico prediction of tumor antigens derived from functional missense mutations of the cancer gene census
por: Khalili, Jahan S., et al.
Publicado: (2012)

The CHEK 2 GENE mutations and the risk of Gastric cancer
por: Teodorczyk, Urszula, et al.
Publicado: (2012)

Multiplexed assays reveal effects of missense variants in MSH2 and cancer predisposition
por: Nielsen, Sofie V., et al.
Publicado: (2021)

Mutations and polymorphisms of genes moderate increase in gastric cancer risk
por: Teodorczyk, Urszula, et al.
Publicado: (2012)

In Silico Analysis of Missense Mutations in LPAR6 Reveals Abnormal Phospholipid Signaling Pathway Leading to Hypotrichosis
por: Raza, Syed Irfan, et al.
Publicado: (2014)

Frameshift Mutations of the hMSH6 Gene in Human Leukemia Cell Lines
por: Hosoya, Noriko, et al.
Publicado: (1998)

Mutations spectrum in hereditary disorders predisposing to occurrence of intestine polyposis in Poland
por: Plawski, Andrzej, et al.
Publicado: (2012)

The influence of selenium concentration and variations in selenoprotein genes on the CHEK2-dependent cancers
por: Gupta, Satish, et al.
Publicado: (2015)

MSH6 syndrome
por: Suchy, Janina, et al.
Publicado: (2008)

Systems patientomics: the virtual in-silico patient
por: Dimitrov, Dimiter V
Publicado: (2014)

Asymmetric properties of rod cGMP Phosphodiesterase 6 (PDE6): structural and functional analysis
por: Qureshi, Bilal M, et al.
Publicado: (2015)

RET gene mutations spectrum in patients with medullary thyroid carcinoma (MTC) from Great Poland region
por: Kaczmarek-Ryś, Marta, et al.
Publicado: (2015)

In silico mutational analysis to identify the role and pathogenicity of BCL-w missense variants
por: Kumari, Poonam, et al.
Publicado: (2022)

A missense mutation in both hMSH2 andAPC in an Ashkenazi Jewish HNPCC kindred: implications for clinical screening
por: YUAN, ZHI QIANG, et al.
Publicado: (1999)

In silico analysis of missense mutations in exons 1–5 of the F9 gene that cause hemophilia B
por: Meléndez-Aranda, Lennon, et al.
Publicado: (2019)

In Silico Analysis of Missense Mutations as a First Step in Functional Studies: Examples from Two Sphingolipidoses
por: Duarte, Ana Joana, et al.
Publicado: (2018)

‘PREMM 1,2,6 MODEL’ as a new gene specific prediction model for Lynch Syndrome: retrospective review of mutation positive cases
por: Gale, J
Publicado: (2012)

Prerecognition Diffusion Mechanism of Human DNA Mismatch Repair Proteins along DNA: Msh2-Msh3 versus Msh2-Msh6
por: Pal, Arumay, et al.
Publicado: (2020)

Heterogeneous constitutional mismatch repair deficiency with MSH6 missense mutation clinically benefits from pembrolizumab and regorafenib combination therapy: a case report and literature review
por: Xie, Tong, et al.
Publicado: (2021)

SPDR-05 PARP INHIBITORS RESTORE TEMOZOLOMIDE SENSITIVITY IN MSH6-DEFICIENT TEMOZOLOMIDE-RESISTANT GLIOBLASTOMA CELLS
por: Higuchi, Fumi, et al.
Publicado: (2019)

Multiple functions for the N-terminal region of Msh6
por: Clark, Alan B., et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_b33g10spls9noq4epckr33mpul